Skip to Main Content

Paper Details

Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone.
JAMA Cardiol
5
2023
Author NameAffiliation
Gerasimos FilippatosNational and Kapodistrian University of Athens, Attikon University Hospital
  • 1 - 1

Datasets

Release 1.2